The European landscape has seen a shifting evolution in the understanding of psychedelics. Long stigmatized, these substances are now be explored for their medical applications. From Germany, where clinical trials are in progress, to the France, where awareness is growing, Europe stands out in this re-evaluation of copyright culture. Nonetheless,